MG
Metagenomi, Inc. Common Stock
MGX · NASDAQ
$1.10 -1.79% (-$0.02)
1M -10.57%
Market Cap $42.5M
P/E Ratio -
Div. Yield -
ROE 63.65%
Piotroski F-Score Weak
2/9Valuation
78 /100
Cheap P/B 0.38x
P/S 3.14x
EV/EBITDA N/A
Growth
82 /100
Growing Rev. growth 13.59%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 689.20%
Op. margin 741.58%
FCF margin 632.67%
Quality
1 /100
Poor ROE 63.65%
ROA 53.81%
Asset turnover 0.08x
Debt
98 /100
Low Current ratio 4.50x
Debt/Equity 0.34x
Net debt/EBITDA N/A
Stability
48 /100
Moderate Rev. volatility 108.17%
EPS volatility 24.86%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MGX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jian Irish
Employees
113
Headquarters
Emeryville
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report